Hugh McTavish
Fondateur chez IGF Oncology LLC
Profil
Hugh McTavish is the founder of SquareX Pharmaceuticals Corp.
He is the Chairman, President, and Chief Executive Officer of the company, which was founded in 2012.
Dr. McTavish is also the founder of IGF Oncology LLC.
Dr. McTavish received a doctorate degree from the University of Minnesota in 1992.
Postes actifs de Hugh McTavish
| Sociétés | Poste | Début |
|---|---|---|
IGF Oncology LLC
 IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Fondateur | - |
SquareX Pharmaceuticals Corp.
 SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Directeur Général | 26/06/2012 |
Formation de Hugh McTavish
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
IGF Oncology LLC
IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Health Technology |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |